Learn why the next frontier in AI governance will involve real-time surveillance of algorithmic performance across institutions with guidance from Akshaya Bhagavathula and Michelle A. Williams.
- Virtual Reality Endpoints Improve Measurement Of Patients' Real-World Benefit
- Can't-Miss Advice On Selecting Your First AI-Enabled Vendor
- The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
- How To Identify Patient-Centric Risks In The TMF With AI And Automation
- How The TMF Demonstrates Patient Safety And Rights In DCTs
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Elevating Rater Training For More Reliable Study Outcomes
Well-trained raters are key to generating high-quality, consistent clinical trial data. Explore a program offering customized training tailored to the experience levels of raters.
-
2023 Technology Adoption Trends And Plateaus
About 85% of industry leaders and managers have had some exposure to AI. Delve into the state of AI adoption experienced throughout 2023 and where the industry is headed concerning digital tool usage.
-
How SaaS Unlocks New Possibilities For Life Science Organizations
The rise of SaaS (software-as-a-service) has transformed industries, including life sciences, by enabling new possibilities. See how it’s already helping life science organizations around the world today.
-
Dysfunctions Of Clinical Trial Vendor Selection And Overcoming Them
Vendor selection often fails due to five common dysfunctions. Identifying and addressing them early improves alignment, trust, and trial performance—avoiding costly delays.
-
Discover The Value Your eTMF Should Deliver
A well-prepared Trial Master File (TMF) is critical to the success of any clinical trial. Because the TMF tells the whole story of a study – including every data point collected and decision made – managing it throughout the course of the trial is challenging.
-
Accelerated Approval As The New "Norm" In Gene Therapy For Rare Diseases
Gene therapy has revolutionized treatment prospects for rare genetic disorders by enabling corrective or replacement strategies at the molecular level.
-
Clinical Trials In The Age Of Cost Caps
On February 7, 2025, the NIH introduced a pivotal policy (NOT-OD-25-068), capping indirect cost recovery at 15% for research grants.
-
Automation Solutions For Safety Document Distribution
Discover how a leading global pharmaceutical company solved the problem of managed the distribution of safety reports by their clinical operations team.
-
The Future Of EDC Systems
Gain insight from EDC users in sponsor organizations and CROs regarding anticipated trends in the next two years and how EDC systems can align with decentralized clinical trials.
-
Improving Quality And Efficiency In TMF Document Processing
By adhering to the principles outlined in this article, learn how teams can be better enabled to carry out efficient, high-quality processing of documents throughout the entirety of a study.